HCA Healthcare (NYSE:HCA) Price Target Lowered to $431.00 at TD Cowen

HCA Healthcare (NYSE:HCA) had its price objective cut by equities research analysts at TD Cowen from $500.00 to $431.00 in a note issued to investors on Monday,MarketScreener reports. The firm presently has a “buy” rating on the stock. TD Cowen’s target price suggests a potential upside of 15.18% from the company’s previous close.

A number of other brokerages have also recently weighed in on HCA. Weiss Ratings cut shares of HCA Healthcare from a “buy (b-)” rating to a “hold (c+)” rating in a report on Tuesday, June 9th. Barclays lowered their target price on HCA Healthcare from $551.00 to $496.00 and set an “overweight” rating for the company in a research note on Monday, April 27th. Wells Fargo & Company reduced their target price on shares of HCA Healthcare from $481.00 to $436.00 and set an “equal weight” rating on the stock in a report on Monday, April 27th. Truist Financial set a $413.00 target price on shares of HCA Healthcare in a research note on Thursday, June 4th. Finally, Robert W. Baird lowered their price objective on HCA Healthcare from $450.00 to $442.00 and set a “neutral” rating for the company in a research report on Wednesday, April 15th. Fifteen research analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, HCA Healthcare has a consensus rating of “Moderate Buy” and an average target price of $503.00.

HCA Healthcare Price Performance

Shares of HCA stock opened at $374.19 on Monday. The firm’s 50-day moving average is $419.68 and its two-hundred day moving average is $468.81. HCA Healthcare has a 12 month low of $330.00 and a 12 month high of $556.52. The company has a market capitalization of $83.01 billion, a PE ratio of 12.88, a price-to-earnings-growth ratio of 1.19 and a beta of 1.12.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings data on Friday, April 24th. The company reported $7.15 earnings per share (EPS) for the quarter, missing the consensus estimate of $7.19 by ($0.04). The company had revenue of $19.11 billion during the quarter, compared to analysts’ expectations of $19.09 billion. HCA Healthcare had a net margin of 8.89% and a negative return on equity of 295.93%. The firm’s quarterly revenue was up 4.3% on a year-over-year basis. During the same quarter last year, the firm posted $6.45 earnings per share. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. Sell-side analysts forecast that HCA Healthcare will post 30.07 EPS for the current year.

Institutional Trading of HCA Healthcare

A number of institutional investors have recently modified their holdings of HCA. State Street Corp increased its position in shares of HCA Healthcare by 1.0% during the fourth quarter. State Street Corp now owns 7,566,643 shares of the company’s stock worth $3,532,563,000 after acquiring an additional 76,039 shares during the last quarter. Capital World Investors increased its stake in HCA Healthcare by 0.8% during the fourth quarter. Capital World Investors now owns 4,999,422 shares of the company’s stock valued at $2,334,040,000 after purchasing an additional 40,086 shares during the last quarter. Geode Capital Management LLC grew its position in shares of HCA Healthcare by 0.4% during the 4th quarter. Geode Capital Management LLC now owns 3,663,705 shares of the company’s stock valued at $1,702,738,000 after buying an additional 13,565 shares during the last quarter. Norges Bank acquired a new stake in shares of HCA Healthcare in the 4th quarter worth about $1,262,513,000. Finally, Arrowstreet Capital Limited Partnership grew its position in HCA Healthcare by 11.9% in the 4th quarter. Arrowstreet Capital Limited Partnership now owns 2,311,112 shares of the company’s stock worth $1,078,966,000 after purchasing an additional 245,887 shares during the last quarter. Hedge funds and other institutional investors own 62.73% of the company’s stock.

About HCA Healthcare

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.